Ocular Therapeutix (OCUL) Interest Coverage Ratio Growth (5y) (2018 - 2026)
Ocular Therapeutix (OCUL) Interest Coverage Ratio Growth (5y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Ocular Therapeutix | 1.93 Bn | 1.93 Bn | 9.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -22.78% |
| Dec 31, 2025 | -10.70% |
| Sep 30, 2025 | -22.88% |
| Jun 30, 2025 | -16.26% |
| Mar 31, 2025 | -16.06% |
| Dec 31, 2024 | -28.62% |
| Sep 30, 2024 | -27.67% |
| Jun 30, 2024 | -59.55% |
| Mar 31, 2024 | -11.65% |
| Dec 31, 2023 | 54.03% |
| Sep 30, 2023 | 30.64% |
| Jun 30, 2023 | 19.10% |
| Mar 31, 2023 | 14.36% |
| Dec 31, 2022 | 17.96% |
| Sep 30, 2022 | 0.52% |
| Jun 30, 2022 | 3.53% |
| Mar 31, 2022 | 2.47% |
| Dec 31, 2021 | 22.48% |
| Sep 30, 2021 | -63.79% |
| Jun 30, 2021 | 14.38% |